Custom DL-based prostate and OAR MRI segmentation software for LDRPBT (MIM Symphony integration)
2026-01-24https://doi.org/10.1148/atlas.1769278113845
121
Overview
Schema Version
https://atlas.rsna.org/schemas/2025-11/model.json
Name
Custom DL-based prostate and OAR MRI segmentation software for LDRPBT (MIM Symphony integration)
Link
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980936
Indexing
Keywords: MRI, Neural Networks, Radiation Therapy, Prostate, Segmentation, Dosimetry, Organs at risk, Brachytherapy
Content: MR, RO, GU
RadLex: RID163, RID49517, RID38870, RID357
Author(s)
Jeremiah W. Sanders
Rajat J. Kudchadker
Chad Tang
Henry Mok
Aradhana M. Venkatesan
Howard D. Thames
Steven J. Frank
Organization(s)
The University of Texas MD Anderson Cancer Center
Version
1.0
License
Text: © RSNA, 2022
URL: https://pubs.rsna.org/journal/ryai
Contact
Jeremiah W. Sanders, gro.nosrednadm@1srednasj
Ethical review
HIPAA-compliant and institutional review board–approved protocol at the University of Texas MD Anderson Cancer Center.
Date
Updated: 2022-03-01
Published: 2022-01-26
Created: 2021-06-14
References
[1] Sanders JW, Kudchadker RJ, Tang C, Mok H, Venkatesan AM, Thames HD, Frank SJ. "Prospective Evaluation of Prostate and Organs at Risk Segmentation Software for MRI-based Prostate Radiation Therapy". Radiology: Artificial Intelligence. 2022;4(2):e210151.. 2022-01-26. doi:10.1148/ryai.210151. PMID: 35391775. PMCID: PMC8980936.
[2] Sanders JW, Lewis GD, Thames HD, et al.. "Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy". Int J Radiat Oncol Biol Phys. 2020;108(5):1292-1303.. 2020-01-01. PMID: 32634543. Available from: https://pubmed.ncbi.nlm.nih.gov/32634543/
Model
Architecture
Fully convolutional networks for semantic segmentation (deep learning).
Availability
Implemented via software interface into a commercial treatment planning system (MIM Symphony); custom in-house algorithm. No public download URL provided.
Clinical benefit
Generates clinical-quality contours of prostate and surrounding organs at risk on MRI to support LDRPBT planning and postimplant dosimetry; potential workflow efficiency improvement and reduced intraobserver variability.
Clinical workflow phase
Clinical decision support and workflow optimization for radiation therapy planning and postimplant quality assessment.
Decision threshold
User-selectable operating point per organ (displayed confidence thresholds spanning 10%–90%); a fixed operating point mode is also available for fully automatic use.
Degree of automation
Automated segmentation with optional user selection of operating point and physician review/refinement; also evaluated in fully automatic mode with fixed thresholds.
Indications for use
Segmentation of prostate and organs at risk (EUS, seminal vesicles, rectum, bladder) on postimplant prostate MRI for low-dose-rate prostate brachytherapy in patients with prostate cancer within radiation oncology treatment planning/QA environments.
Input
Postimplant prostate MRI (turbo spin-echo or fully balanced SSFP sequences).
Instructions
Run autosegmentation; select per-organ operating point if desired; physician (radiation oncologist) reviews and refines contours as needed; proceed to dose-volume histogram analysis within the treatment planning system.
Limitations
Prospective evaluation on a small single-institution cohort (n=30). Preimplant MRIs not evaluated. Algorithm developed and evaluated at the same institution. Highest variability and need for refinements observed in EUS contours, reflecting variability in human annotations. Biodegradable hydrogel rectal spacers were underrepresented in development data (<1%) though algorithm handled their presence; potential threshold sensitivity at low decision values.
Output
CDEs: RDE101, RDE93, RDE1551, RDE103, RDE1549
Description: Segmentation masks/contours for prostate and organs at risk.
Recommendation
Use as an automatic contouring aid for MRI-based LDRPBT with physician oversight; either user-selected or fixed operating points acceptable given similar dosimetry outcomes.
Reproducibility
Deterministic predictions for a given model and operating point; eliminates intraobserver variability component in contouring.
Sustainability
Execution time approximately 1 minute or less per MRI for autosegmentation (reported qualitatively).
Use
Intended: Image segmentation
User
Intended: Physician, Other, Subspecialist diagnostic radiologist, Researcher